Increasing demands for clinical trial disclosure and transparency are dominating the medical journals and making their way into more general news outlets as well. Recently, Dr Ben Goldacre, Transparency Advocate, said “Clinical trial information is being routinely and legally withheld and this needs to end". While a few may see this as a distraction, many life sciences executives are prioritizing their role in strengthening customer trust by implementing disclosure best practices across their organization.
1 Comment | Click here to read/write comments
Topics: clinical trial transparency